Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+7.12%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$35.8B
Cap. Flow
% of AUM
-178.2%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$78.3M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$69.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$67.8M |
| 4 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$51.6M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$49.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.03B |
| 3 |
Apple
AAPL
|
+$1.62B |
| 4 |
Amazon
AMZN
|
+$1.15B |
| 5 |
Meta Platforms (Facebook)
META
|
+$886M |
Sector Composition
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Day One Biopharmaceuticals
DAWN
$729M
| $36.1K | ﹤0.01% |
2,609
-19,254
| -88% | -$266K |
|
1302
Vir Biotechnology
VIR
$695M
| $36K | ﹤0.01% |
4,062
-45,463
| -92% | -$403K |
|
1303
Vesta Real Estate
VTMX
$2.37B
| $35.9K | ﹤0.01% |
+1,196
| New | +$35.9K |
|
1304
Sana Biotechnology
SANA
$828M
| $35.7K | ﹤0.01% |
6,613
-50,922
| -89% | -$275K |
|
1305
Xencor
XNCR
$613M
| $35.3K | ﹤0.01% |
1,841
-32,101
| -95% | -$616K |
|
1306
Zillow
Z
$21.3B
| $35.1K | ﹤0.01% |
751
-16,825
| -96% | -$787K |
|
1307
Open Text
OTEX
$9.07B
| $35K | ﹤0.01% |
+1,172
| New | +$35K |
|
|
ALEX
1308
Alexander & Baldwin
ALEX
$1.34B
| $35K | ﹤0.01% |
2,091
-31,737
| -94% | -$531K |
|
|
MOMO
1309
Hello Group
MOMO
$1.19B
| $34.5K | ﹤0.01% |
5,738
-102,974
| -95% | -$619K |
|
|
DEA
1310
Easterly Government Properties
DEA
$1.07B
| $34.5K | ﹤0.01% |
1,120
-605,536
| -100% | -$18.6M |
|
1311
Teradata
TDC
$2B
| $34.2K | ﹤0.01% |
987
-10,420
| -91% | -$361K |
|
1312
Futu Holdings
FUTU
$25.9B
| $33.8K | ﹤0.01% |
+515
| New | +$33.8K |
|
1313
iShares ESG Optimized MSCI USA ETF
SUSA
$3.63B
| $33.8K | ﹤0.01% |
+300
| New | +$33.8K |
|
1314
Global X FinTech ETF
FINX
$300M
| $33.7K | ﹤0.01% |
1,342
-279,890
| -100% | -$7.02M |
|
1315
Prothena Corp
PRTA
$442M
| $33K | ﹤0.01% |
1,605
-26,307
| -94% | -$540K |
|
1316
Enliven Therapeutics
ELVN
$1.18B
| $32.9K | ﹤0.01% |
+1,404
| New | +$32.9K |
|
1317
Disc Medicine
IRON
$2.08B
| $32.7K | ﹤0.01% |
+738
| New | +$32.7K |
|
1318
Arcutis Biotherapeutics
ARQT
$2.07B
| $32.6K | ﹤0.01% |
3,456
-43,198
| -93% | -$407K |
|
1319
Grupo Aeroportuario Centro Norte
OMAB
$5.41B
| $32.6K | ﹤0.01% |
+487
| New | +$32.6K |
|
1320
4D Molecular Therapeutics
FDMT
$318M
| $32.3K | ﹤0.01% |
1,544
-18,554
| -92% | -$388K |
|
1321
Roku
ROKU
$13.9B
| $32.2K | ﹤0.01% |
+544
| New | +$32.2K |
|
|
VRNA
1322
Verona Pharma
VRNA
$9.21B
| $32.1K | ﹤0.01% |
+2,081
| New | +$32.1K |
|
1323
Collegium Pharmaceutical
COLL
$1.18B
| $31.7K | ﹤0.01% |
977
-15,001
| -94% | -$487K |
|
|
VRE
1324
Veris Residential
VRE
$1.49B
| $31.5K | ﹤0.01% |
2,125
-37,536
| -95% | -$557K |
|
1325
Ocular Therapeutix
OCUL
$2.23B
| $31.3K | ﹤0.01% |
4,624
-48,832
| -91% | -$330K |
|